Nov 18 (Reuters) - Canadian fund Brookfield

plans to offer about 7 billion euros ($7.4 billion) for Spanish

drugmaker Grifols after finishing due diligence, news

website El Confidencial reported on Monday, citing sources close

to the matter.

Brookfield is evaluating offering 10.5 euros per share in a

public tender offer, El Confidencial said, below Grifols'

closing market price on Friday of 11.125 euros.

The Canadian private equity firm said in September it was

interested in launching a takeover bid jointly with the Grifols

family, pending successful completion of due diligence.

The company has lost about 30% of its market value since

January, when short-seller fund Gotham City Research accused

Grifols of overstating earnings and understating debt, which

Grifols denied.

Spokespeople at Brookfield and Grifols did not immediately

respond to requests for comment.

($1 = 0.9486 euros)